Increased expression of NOTCH1, NOTCH3, HES1 and HEY1 is also observed in pre- and post-treatment osteosarcoma patient samples with NOTCH3 expression associated with poorer 5-year survival [114]. Here, NOTCH3 is linked to osteosarcoma.